Johan Le Fel is an expert in Oncology at Centre Henri Becquerel (France). Johan Le Fel has authored 14 publications, the most recent in 2024, and is an investigator in 1 clinical trial. SLR score: 36 (community average: 125). How the SLR is computed.

LeadR Profile

Johan Le Fel Centre Henri Becquerel France
36 ScienceLeadR Reputation 36
Network Map

Oncology

Subspecialties:

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2013 - 2024

Source: PubMed

Centre Henri Becquerel

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 14

Citations

Citations: 314 1st author: 2 Last author: 0 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
[Multidisciplinary support in cancer care: Pair working physician/psychologist in the support of children of affected parents by cancer].
PMID 38821774 — neoplasms, physicians, child
Bull Cancer20240
Digital cognitive stimulation in elderly breast cancer patients: the Cog-Tab-Age feasibility study.
PMID 38822324 — radiotherapy, exercise, feasibility studies, breast neoplasms, neoplasms, tablets, drug therapy, aged, breast, therapeutics, cognition, complementary therapies, chemotherapy, cognitive training
BMC Complement Med Ther20241
Cognitive change in breast cancer patients up to 2 years after diagnosis.
PMID 36571503 — memory, short-term, breast neoplasms, neoplasms, executive function, drug therapy, breast, diagnosis, therapeutics, memory, chemotherapy
J Natl Cancer Inst202222
Cognitive Impairment in Patients with Breast Cancer before Surgery: Results from a CANTO Cohort Subgroup.
PMID 32611581 — breast neoplasms, neoplasms, cognitive dysfunction, fatigue, breast, cognition disorders, therapeutics, genetic markers, cognition
Cancer Epidemiol Biomarkers Prev202027
Treatment and outcomes of older versus younger women with HER2-positive metastatic breast cancer in the real-world national ESME database.
PMID 34624756 — breast neoplasms, neoplasms, drug therapy, breast, therapeutics, breast diseases, chemotherapy
Breast202113

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 1

By status:

Active not recruiting 1

By type:

Interventional 1

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 1
multicentric5to9 0
multicentricup10 0

Main Topics

LeadR Networks

Main global connection map